NIH-funded research R01 grant

Understanding lung development in premature infants

Official title: Integrated Molecular and Cellular Drivers of Alveologenesis

Funded at Vanderbilt University Medical Center · NIH-11088232 · Data updated 2026-11-12

This study is looking at how lung problems in premature babies, called bronchopulmonary dysplasia (BPD), happen and aims to find ways to help their lungs grow better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startMay 20, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$682,722
NIH project number5R01HL168556-03
Project IDNIH-11088232 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are neonates born between 23-32 weeks of gestation who are at risk for bronchopulmonary dysplasia.

Less likely to help

Patients who are not premature or who do not have any lung development issues may not benefit from this research.

What this research studies

This research investigates the mechanisms behind bronchopulmonary dysplasia (BPD), a serious lung condition affecting premature infants. By examining the transition from saccular to alveolar lung development, the study aims to identify the cellular and molecular processes that lead to impaired lung growth. Using advanced imaging techniques and a neonatal injury model, researchers will explore how specific signaling pathways influence cell behavior and lung architecture. The ultimate goal is to uncover potential therapeutic targets for preventing or treating BPD in vulnerable neonates.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve lung development and reduce the incidence of bronchopulmonary dysplasia in premature infants.

How similar studies have gone: Other research has shown promise in understanding lung development and BPD, but this approach utilizing advanced imaging and specific signaling pathways is relatively novel.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Sucre, Jennifer Malcolmsrygley — Vanderbilt University Medical Center
  • Study coordinator: Sucre, Jennifer Malcolmsrygley

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.